Back

Body mass index, silent coronary artery disease and the impact of adopting healthy lifestyle and sexual performance on the risk of major adverse cardiovascular events in erectile dysfunction patients

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Cardiovascular Disease in the Elderly ESC Premium Access ESC Congress 2020

About the speaker

Photo
Mr Nikolaos Ioakeimidis

University of Athens, Athens (Greece)

155 More presentations in this session

Presentation thumbnail
Implementation study of CT calcium score in patients with atypical angina pectoris and non-specific thoracic complaints in primary care: rationale, objectives, and design of the CONCRETE study
Miss M. Koopman (Groningen, NL)
Abstract Slides
Presentation thumbnail
Serum uric acid possibly associated with abnormal left ventricular diastolic function in healthy individuals
Doctor C. Liu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Characteristics and health status of patients with and without confirmed HFpEF
Professor C. Deaton (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Evaluating the diagnostic and prognostic value of cardiac biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy
Mr A. Nikhanj (Edmonton, CA)
Abstract Slides
Presentation thumbnail
Heart involvement in type 1 and type 2 myotonic dystrophy. Insights from a 10-year follow-up study.
Doctor F. Fioravanti (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in Special Populations ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and impact of high BMI in CAD patients
7 April 2022
thumbnail
Congress Presentation
Erectile dysfunction, generalized vascular disease and the long term effects of smoking exposure on arterial properties: time is of the essence
28 August 2022
thumbnail
Congress Presentation
Androgen deprivation therapy with agonists of GnRH: cardiovascular adverse events and comorbidity considerations in patients with prostate cancer
27 August 2021
thumbnail
Congress Presentation
Sexual functioning after the age of 40 in adults with moderate or severe congenital heart disease
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources